Pier Luigi Luigi Zinzani (Pierluigi Luigi Zinzani, P L Zinzani, PierLuigi Zinzani, Pier L Zinzani, Pierluigi Zinzani, Pier Luigi Zinzani, Pier-Luigi Zinzani)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 111

Top Venues

Hematological oncology

Blood advances

Blood

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Broccoli, Lisa Argnani, Laura Nanni, Vittorio Stefoni, Cinzia Pellegrini, Beatrice Casadei, Gabriele Gugliotta, Matteo Carella, Paolo Elia Coppola, Gianmarco Bagnato, Pier Luigi Luigi Zinzani
Single-agent rituximab is an effective salvage therapy in pretreated hairy cell leukemia patients. Blood advances (2023)
Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics 15 (3) (2023)
Zeno Pasquini, Alice Toschi, Beatrice Casadei, Cinzia Pellegrini, Alessandra D'Abramo, Serena Vita, Alessia Beccacece, Linda Bussini, Maria Clara Chionsini, Nicola Dentale, Alessia Cantiani, Tiziana Lazzarotto, Michele Bartoletti, Emanuele Nicastri, Pier Luigi Luigi Zinzani, Maddalena Giannella, Pierluigi Viale
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection. Hematological oncology (2023)
Pier Luigi Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A Johnson, Neha Mehta-Shah, Julie M Lisano, Rachael Wen, Alev Akyol, Alison J Moskowitz
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up. Blood advances (2023)
Emanuela Foglia, Elisabetta Garagiola, Vito Ladisa, Alessandro Rambaldi, Roberto Cairoli, Simona Sammassimo, Emanuela Omodeo Salè, Pier Luigi Luigi Zinzani, Marco Esposti, Luisa Alberti, Maria Franca Mulas, Eleonora Melis, Stefania Onnis, Maurizio Marcias, Vittorio Satta, Davide Croce
Multidimensional Results and Reflections on CAR-T: The Italian Evidence. International journal of environmental research and public health 20 (5) (2023)
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Cristina Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo Giovanni Giovanni Carrabba, Christian Chabanon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Roch Houot, Gloria Iacoboni, Ulrich Jäger, Marie José Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Peric, Claire Roddie, Annalisa Ruggeri, Fermin M Sanchez-Guijo, Isabel Sánchez-Ortega, Dominik Schneidawind, Maria-Luisa Schubert, John A Snowden, Catherine Thieblemont, Max S Topp, Pier Luigi Luigi Zinzani, John G Gribben, Chiara Bonini, Anna Sureda Balari, Ibrahim Yakoub Agha
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations. Blood (2023)
Michael L Wang, Wojciech Jurczak, Pier Luigi Luigi Zinzani, Toby Andrew Eyre, Chan Yoon Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian W Flinn, Benoît Tessoulin, Alvaro J Alencar, Shuo Ma, David John Lewis, Ewa Lech-Maranda, Joanna M Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S Tam, Tahla Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S Fenske, John Francis Seymour, Andrew D Zelenetz, Binoj Nair, Donald E Tsai, Minna Balbas, Richard A Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R Mato, Nirav N Shah
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Brad S Kahl, Weiyun Z Ai, John Radford, Melham M Solh, Kirit M Ardeshna, Brian T Hess, Matthew A Lunning, Pier Luigi Luigi Zinzani, Anastasios Stathis, Carmello Carlo-Stella, Izidore S Lossos, Paolo F Caimi, Sunwoo Han, Fei Yang, Russ A Kuker, Craig H Moskowitz
PET/CT-biomarkers enable risk stratification of patients with relapsed/refractory diffuse large B-cell lymphoma enrolled in the LOTIS-2 clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Pietro Quaglino, Nicola Pimpinelli, Pier Luigi Luigi Zinzani, Marco Paulli, Stefano Pileri, Emilio Berti, Lorenzo Cerroni, Joan Guitart, Youn H Kim, Serena Rupoli, Marco Santucci, Gabriele Simontacchi, Maarten Vermeer, Richard Hoppe, Barbara Pro, Steven H Swerdlow, Giovanni Barosi
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel. Hematological oncology (2023)
Daniel Noerenberg, Franziska Briest, Cornelius Hennch, Kenichi Yoshida, Raphael Hablesreiter, Yasuhide Takeuchi, Hiroo Ueno, Annette M Staiger, Marita Ziepert, Fazila Asmar, Benjamin N Locher, Erika Toth, Thomas Weber, Rose-Marie Amini, Wolfram Klapper, Maria Bouzani, Viola Poeschel, Andreas Rosenwald, Gerhard Held, Elias Campo, Naveed Ishaque, Kostas Stamatopoulos, George Kanellis, Ioannis Anagnostopoulos, Lars Bullinger, Neta Goldschmidt, Pier Luigi Luigi Zinzani, Csaba Bödör, Richard Rosenquist, Theodoros P Vassilakopoulos, German Ott, Seishi Ogawa, Frederik Damm
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mehdi Hamadani, Alexander I Spira, Xiaolei Zhou, Laura Liao, Lei Chen, John Radford, Weiyun Z Ai, Melhem M Solh, Kirit M Ardeshna, Brian T Hess, Paolo F Caimi, Anastasios Stathis, Carmelo Carlo Stella, Juan Pablo Alderuccio, Brad S Kahl, Ying Wang, Yajuan Gu Qin, Zhiying Cindy Xu, Pier Luigi Luigi Zinzani
Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial. Blood advances (2023)
Pier Luigi Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, Francesco Zaja, Giovanni Barosi
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel. Hematological oncology (2023)
Emmanuel Bachy, Kerry J Savage, Huiqiang Huang, Yok-Lam L Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Hai-Yan Yang, Siguo Hao, Jianda Hu, Ke-Shu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José Maria Ferreri, Gandhi Laurent Damaj, Wei Zhang, Hui Liu, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason C Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Luigi Zinzani
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open label phase 2 study. Blood advances (2023)
Francesco Peyronel, Julien Haroche, Campochiaro Corrado, Francesco Pegoraro, Zahir Amoura, Alessandro Tomelleri, Martina Mazzariol, Matthias Papo, Giulio Cavalli, Giuseppe Daniele Benigno, Paride Fenaroli, Chrysanthos Grigoratos, Maria Cecilia Mengoli, Arturo Bonometti, Emilio Berti, Gustavo Savino, Mauro Cives, Iria Neri, Gaetano Pacinella, Antonino Tuttolomondo, Massimo Marano, Francesco Muratore, Andreina Manfredi, Alessandro Broccoli, Pier Luigi Luigi Zinzani, Biagio Didona, Chiara Massaccesi, Andrea Buono, Enrico Ammirati, Vito Di Lernia, Lorenzo Dagna, Augusto Vaglio, Fleur Cohen-Aubart
EPIDEMIOLOGY AND GEOGRAPHIC CLUSTERING OF ERDHEIM-CHESTER DISEASE IN ITALY AND FRANCE. Blood (2023)
Emanuela Foglia, Elisabetta Garagiola, Vito Ladisa, Alessandro Rambaldi, Roberto Cairoli, Simona Sammassimo, Emanuela Omodeo Salè, Pier Luigi Luigi Zinzani, Marco Esposti, Luisa Alberti, Maria Franca Mulas, Eleonora Melis, Stefania Onnis, Maurizio Marcias, Vittorio Satta, Davide Croce
Multidimensional Results and Reflections on CAR-T: The Italian Evidence. International journal of environmental research and public health 20 (5) (2023)
Andrés José Maria Ferreri, Pier Luigi Luigi Zinzani, Carlo Messina, Diletta Valsecchi, Maria Chiara Rendace, Eleonora Premoli, Elisa Giacomini, Chiara Veronesi, Luca Degli Esposti, Paola Di Matteo
Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis. Cancers 15 (17) (2023)
Philippe Armand, Pier Luigi Luigi Zinzani, Jee Hun Lee, Nathalie A Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A Shipp, Alex F Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H Moskowitz
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy in relapsed/refractory classical Hodgkin lymphoma. Blood (2023)
Ginevra Lolli, Lisa Argnani, Guido Gini, Beatrice Casadei, Cinzia Pellegrini, Monica Tani, Eleonora Prete, Michele Cimminiello, Francesca Bonifazi, Pier Luigi Luigi Zinzani
Pixantrone as bridging therapy to allogeneic transplantation or in CAR T-cell pathway in patients with diffuse large B-cell lymphoma. Hematological oncology (2023)
Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics 15 (3) (2023)
Mehdi Hamadani, Morton Coleman, Ralph Boccia, Juraj Duras, Martin Hutchings, Pier Luigi Luigi Zinzani, Raul Cordoba, Mariana Bastos Oreiro, Vanessa Williams, Huiqing Liu, Michael Stouffs, Peter Langmuir, Juan-Manuel Sancho
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study. Hematological oncology (2023)
Pier Luigi Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C Oliveira, Yuqin Song, Qingyuan Zhang, Michele Merli, Krimo Bouabdallah, Peter Ganly, Huilai Zhang, Roderick Johnson, Alejandro Martín García-Sancho, Mariano Provencio Pulla, Marek Trněný, Sam Yuen, Herve Tilly, Edwin Kingsley, Gayane Tumyan, Sarit E Assouline, Rebecca Auer, Elena Ivanova, Pil Kim, Sha Huang, Richard Delarue, Judith Trotman
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Stephen Samuel Opat, Alessandra Tedeschi, Bei Hu, Kim M Linton, Pamela McKay, Sophie Leitch, Morton Coleman, Pier Luigi Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Peter J Browett, Xiaoyan Ke, Catherine Thieblemont, Kirit M Ardeshna, Fontanet Bijou, Patricia A Walker, Eliza A Hawkes, Shir Jing Ho, Ke-Shu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study. Blood advances (2023)
Malgorzata Mikulska, Diletta Testi, Chiara Russo, Elisa Balletto, Chiara Sepulcri, Linda Bussini, Chiara Dentone, Federica Magne, Sílvia Policarpo, Caterina Campoli, Filippo Miselli, Alessandro Cilli, Chiara Ghiggi, Sara Aquino, Carmen Di Grazia, Maddalena Giannella, Daniele Roberto Giacobbe, Antonio Vena, Anna Maria Raiola, Francesca Bonifazi, Pier Luigi Luigi Zinzani, Michele Cavo, Roberto M Lemoli, Emanuele Angelucci, Pierluigi Viale, Matteo Bassetti, Michele Bartoletti
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders. British journal of haematology (2023)
Stephen M Ansell, Paul J Bröckelmann, Gottfried von Keudell, Jee Hun Lee, Armando Santoro, Pier Luigi Luigi Zinzani, Graham P Collins, Jonathon B Cohen, Jan Paul de Boer, John Kuruvilla, Kerry J Savage, Marek Trněný, Mariano Provencio, Ulrich Jäger, Wolfgang Willenbacher, Rachael Wen, Alev Akyol, Joanna Mikita-Geoffroy, Margaret A Shipp, Andreas Michael Engert, Philippe Armand
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study. Blood advances (2023)
Emanuela Foglia, Elisabetta Garagiola, Vito Ladisa, Alessandro Rambaldi, Roberto Cairoli, Simona Sammassimo, Emanuela Omodeo Salè, Pier Luigi Luigi Zinzani, Marco Esposti, Luisa Alberti, Maria Franca Mulas, Eleonora Melis, Stefania Onnis, Maurizio Marcias, Vittorio Satta, Davide Croce
Multidimensional Results and Reflections on CAR-T: The Italian Evidence. International journal of environmental research and public health 20 (5) (2023)
Chun Liu, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Luigi Zinzani, Pierluigi Viale, Francesca Bonifazi, Federico Pea
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics 15 (3) (2023)
Pier Luigi Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Maria Fogliatto, Alejandro Martín García-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170. Blood (2023)
Carmelo Carlo-Stella, Pier Luigi Luigi Zinzani, Anna Sureda, Luis Araújo, Olivier Casasnovas, Cecilia Carpio, Su-Peng Yeh, Krimo Bouabdallah, Guillaume Cartron, Won Seog Kim, Raul Cordoba, Youngil Koh, Alessandro Re, Daniela Alves, Martine Chamuleau, Steven Le Gouill, Armando López-Guillermo, Ilídia Moreira, Marjolein W M van der Poel, Giovanni Abbadessa, Robin Meng, Ran Ji, Lucie Lépine, Rao Saleem, Vincent Ribrag
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma. Hematological oncology (2022)
Ginevra Lolli, Margherita Ursi, Michele Dicataldo, Beatrice Casadei, Gianluca Storci, Lisa Argnani, Francesca Bonifazi, Pier Luigi Luigi Zinzani
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient. Leukemia & lymphoma 63 (12) (2022)
Mark Bishton, Scott Marshall, Jatinder Harchowal, Gilles Salles, Camille Golfier, Alessandra Tucci, Alicia Rodriguez Fernández, Jose Javier Sanchez Blanco, Monica Bocchia, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe. Hematological oncology 40 (3) (2022)
Vittorio Stefoni, Lisa Argnani, Matteo Carella, Beatrice Casadei, Alice Morigi, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Paolo Elia Coppola, Pier Luigi Luigi Zinzani
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience. Journal of cancer research and clinical oncology (2022)
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H Kim, Pietro Quaglino, Pier Luigi Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E Akilov, Larisa Geskin, Jose Antonio Sanches, Pablo Luis Ortiz-Romero, Michael Weichenthal, David C Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, Henry Miles Prince
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. Blood advances 5 (23) (2022)
Laurence de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martínez, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry J Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Vittorio Stefoni, Cinzia Pellegrini, Lisa Argnani, Paolo Corradini, Anna Dodero, Lorella Orsucci, Stefano Volpetti, Pier Luigi Luigi Zinzani
Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study. Hematological oncology 40 (2) (2022)
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, Jonathan W Friedberg, Andrea Gallamini, Eliza A Hawkes, David C Hodgson, Peter W M Johnson, Brian K Link, Eric Mou, Kerry J Savage, Pier Luigi Luigi Zinzani, Matthew J Maurer, Andrew M Evens
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Pier Luigi Luigi Zinzani, Maurizio Martelli, Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Paolo Sportoletti, Alessandra Tedeschi, Marzia Varettoni, Chiara Rusconi
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement. Hematological oncology 40 (4) (2022)
Kerry J Savage, Steven M Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Judith Trotman, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trněný, Sam Yuen, Pier Luigi Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A O'Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood advances 6 (19) (2022)
Juan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, Anne W Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B Alpert, Adam J Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J Castillo, Lisa Argnani, Timothy J Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M Reis, Deukwoo Kwon, Jonathan Struan Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian K Link, Constantine N Logothetis, Alex F Herrera, Jonathan W Friedberg, Brad S Kahl, Stefano Luminari, Pier Luigi Luigi Zinzani, Izidore S Lossos
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood advances 6 (7) (2022)
Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Maurizio Martelli, Paolo Sportoletti, Chiara Rusconi, Pier Luigi Luigi Zinzani, Alessandra Tedeschi, Marzia Varettoni
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement. Hematological oncology 40 (3) (2022)
Mark J Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani, Kamel Laribi
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. EJHaem 4 (1) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martínez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Andre Salles, Jesús San F Miguel, John Francis Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Peter Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew John Davies, Brunangelo Falini, Irene M Ghobrial, Mariusz A Wasik, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji K Kumar, Ann Steward LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria-Victoria Mateos-Manteca, Elizabeth A Macintyre, Ari M Melnick, Judith Trotman, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Angel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier Luigi Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140 (11) (2022)
Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucia L Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martín García-Sancho, Pier Luigi Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma. Blood advances 6 (12) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Beatrice Casadei, Lisa Argnani, Alessandro Broccoli, Caterina Patti, Piero Maria Stefani, Antonio Cuneo, Gloria Margiotta Casaluci, Chiara Rusconi, Guido Gini, Fabrizio Pane, Francesco D'Alò, Debora Luzi, Maria Cantonetti, Samantha Pozzi, Gerardo Musuraca, Chiara Rosignoli, Annalisa Arcari, Sofya Kovalchuk, Monica Tani, Maria Chiara Tisi, Mario Petrini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study. Cancers 14 (3) (2022)
Mark J Bishton, Gilles Salles, Camille Golfier, Wolfgang Knauf, Monica Bocchia, Deborah Turner, Borhane Slama, Jatinder Harchowal, Scott Marshall, Alberto Bosi, Juan José Bargay Lleonart, Manfred Welslau, SooKyoung Kim, Young Nam Lee, Pier Luigi Luigi Zinzani, Kamel Laribi
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe. EJHaem 4 (1) (2022)
Livio Pagano, Marianna Criscuolo, Alessandro Broccoli, Alfonso Piciocchi, Marzia Varettoni, Eugenio Galli, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Annamaria Frustaci, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Massimo Offidani, Beatrice Casadei, Maria Elena Nizzoli, Maria Lucia De Luca, Luana Fianchi, Marina Motta, Luca Guarnera, Edoardo Simonetti, Andrea Visentin, Francesco Vassallo, Marina Deodato, Chiara Sarlo, Attilio Olivieri, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Luigi Zinzani
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study. Blood cancer journal 12 (7) (2022)
Alessandro Broccoli, Lisa Argnani, Paolo Elia Coppola, Marianna Gentilini, Gianmarco Bagnato, Ginevra Lolli, Matteo Carella, Laura Nanni, Alice Morigi, Beatrice Casadei, Cinzia Pellegrini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series. Tumori (2022)
Georg Hess, Martin Dreyling, Lucie Oberic, Eva Gine, Pier Luigi Luigi Zinzani, Kim Linton, Adam Vilmar, Mats Jerkeman, Jenny M H Chen, Anke Ohler, Stephan Stilgenbauer, Catherine Thieblemont, Jonathan Lambert, Vittorio Ruggero Zilioli, Juan-Manuel Sancho, Ana Jiménez-Ubie, Luca Fischer, Toby Andrew Eyre, Sam Keeping, Julie E Park, James J Wu, Rubina Siddiqi, John Reitan, Sally Wade, Gilles Salles
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study. British journal of haematology (2022)
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, Jonathan W Friedberg, Andrea Gallamini, Eliza A Hawkes, David C Hodgson, Peter W M Johnson, Brian K Link, Eric Mou, Kerry J Savage, Pier Luigi Luigi Zinzani, Matthew J Maurer, Andrew M Evens
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Matthew S Davids, Owen A O'Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S Fenske, Pier Luigi Luigi Zinzani, Manish R Patel, Nilanjan Ghosh, Bruce D Cheson, Enrico Derenzini, Danielle M Brander, James A Reeves, Wanda Knopińska-Posłuszny, John N Allan, Tycel Phillips, Paolo F Caimi, Ewa Lech-Maranda, John M Burke, Richy Agajanian, Ruth Pettengell, Lori A Leslie, Chan Yoon Y Cheah, Gustavo Fonseca, James Essell, Julio C Chavez, John M Pagel, Jeff P Sharman, Yanzhi Hsu, Hari P Miskin, Peter Sportelli, Michael S Weiss, Ian W Flinn
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies. Blood advances 5 (23) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Eleonora Porcu, Linda Cipriani, Maria Dirodi, Pierandrea De Iaco, Anna Myriam Perrone, Pier Luigi Luigi Zinzani, Mario Taffurelli, Claudio Zamagni, Patrizia Maria Ciotti, Leonardo Notarangelo, Nilla Calza, Giuseppe Damiano
Successful Pregnancies, Births, and Children Development Following Oocyte Cryostorage in Female Cancer Patients During 25 Years of Fertility Preservation. Cancers 14 (6) (2022)
Alessandro Broccoli, Lisa Argnani, Matthew Cross, Agnieszka Janus, Elsa Maître, Xavier Troussard, Tadeusz Robak, Claire Dearden, Monica Else, Daniel Catovsky, Pier Luigi Luigi Zinzani
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia. Blood advances 6 (14) (2022)
Pier Luigi Luigi Zinzani, Giorgio Minotti
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. Journal of cancer research and clinical oncology (2021)
Sriram Balasubramanian, Songbai Wang, Christopher Major, Brendan Hodkinson, Michael Schaffer, Laurie H Sehn, Peter Johnson, Pier Luigi Luigi Zinzani, Jodi Carey, S Martin Shreeve, Steven Sun, John Gerecitano, Jessica Vermeulen, Louis M Staudt, Wyndham Wilson
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib. British journal of haematology 194 (1) (2021)
Reid W Merryman, Luca Castagna, Laura Giordano, Vincent T Ho, Paolo Corradini, Anna Guidetti, Beatrice Casadei, David A Bond, Samantha M Jaglowski, Michael A Spinner, Sally Arai, Robert Lowsky, Gunjan L Shah, Miguel-Ángel Perales, Jean Marc Schiano De Colella, Didier Blaise, Alex F Herrera, Geoffrey Shouse, Chloe Spilleboudt, Stephen M Ansell, Yago Nieto, Talha Badar, Mehdi Hamadani, Tatyana A Feldman, Lori Dahncke, Anurag K Singh, Joseph P McGuirk, Taiga Nishihori, Julio Chavez, Anthony V Serritella, Justin Kline, Mohamad Mohty, Rémy Duléry, Aspasia Stamatoulas, Roch Houot, Guillaume Manson, Marie-Pierre Moles-Moreau, Corentin Orvain, Kamal Bouabdallah, Dipenkumar Modi, Radhakrishnan Ramchandren, Lazaros Lekakis, Amer Beitinjaneh, Matthew J Frigault, Yi-Bin Chen, Ryan C Lynch, Stephen D Smith, Uttam Rao, Michael Byrne, Jason T Romancik, Jonathon B Cohen, Sunita Nathan, Tycel Phillips, Robin M Joyce, Maryam Rahimian, Asad Bashey, Hatcher J Ballard, Jakub Svoboda, Valter Torri, Martina Sollini, Chiara De Philippis, Massimo Magagnoli, Armando Santoro, Philippe Armand, Pier Luigi Luigi Zinzani, Carmello Carlo-Stella
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma. Leukemia 35 (9) (2021)
Pier Luigi Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A Johnson, José S R Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Michael J Dickinson, Andrew Bruce McDonald, Muhit Özcan, Naohiro Sekiguchi, Ying Zhu, Monika Raut, Todd L Saretsky, Akash Nahar, John George Kuruvilla
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. Blood advances (2021)
Alessandro Broccoli, Lisa Argnani, Laura Nanni, Carolina Terragna, Elena Sabattini, Giulia Gabrielli, Vittorio Stefoni, Cinzia Pellegrini, Beatrice Casadei, Alice Morigi, Ginevra Lolli, Matteo Carella, Paolo Elia Coppola, Pier Luigi Luigi Zinzani
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience. American journal of hematology 96 (10) (2021)
Alex F Herrera, Catherine Burton, John Radford, Fiona Miall, William Townsend, Armando Santoro, Pier Luigi Luigi Zinzani, David Lewis, Camilla Fowst, Satjit Brar, Bo Huang, Aron Thall, Graham P Collins
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial. Blood advances 5 (17) (2021)
Beatrice Casadei, Lisa Argnani, Serafina Guadagnuolo, Cinzia Pellegrini, Vittorio Stefoni, Alessandro Broccoli, Laura Nanni, Alice Morigi, Ginevra Lolli, Maria Guarino, Luca Spinardi, Elisabetta Pierucci, Stefano Fanti, Michele Bartoletti, Michele Dicataldo, Sabattini Elena, Francesca Bonifazi, Pier Luigi Luigi Zinzani
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. Cancers 13 (19) (2021)
Chiara Tarantelli, Lisa Argnani, Pier Luigi Luigi Zinzani, Francesco Bertoni
PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients. Cancers 13 (21) (2021)
Francesca Bonifazi, Irene Defrancesco, Jacopo Olivieri, Francesco Barbato, Paolo Lopedote, Michele Dicataldo, Mariarosaria Sessa, Elisa Dan, Barbara Sinigaglia, Luca Zazzeroni, Simonetta Rizzi, Cristina Tassi, Beatrice Casadei, Pier Luigi Luigi Zinzani, Mario Arpinati
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas. Bone marrow transplantation 56 (9) (2021)
Pier Luigi Luigi Zinzani, Pietro Quaglino, Silvia Alberti Violetti, Maria Cantonetti, Gaia Goteri, Francesco Onida, Marco Paulli, Serena Rupoli, Giovanni Barosi, Nicola Pimpinelli
Critical concepts and management recommendations for cutaneous T-cell lymphoma: A consensus-based position paper from the Italian Group of Cutaneous Lymphoma. Hematological oncology 39 (3) (2021)
Nathan H Fowler, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A Reeves, Wanda Knopińska-Posłuszny, Chan Yoon Y Cheah, Tycel Jovelle Phillips, Ewa Lech-Maranda, Bruce D Cheson, Paolo F Caimi, Sebastian Grosicki, Lori A Leslie, Julio C Chavez, Gustavo Fonseca, Sunil Babu, Daniel James Hodson, Spencer H Shao, John M Burke, Jeff P Sharman, Jennie Y Law, John M Pagel, Hari P Miskin, Peter Sportelli, Owen A O'Connor, Michael S Weiss, Pier Luigi Luigi Zinzani
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)
Alessandro Broccoli, Carolina Terragna, Laura Nanni, Marina Martello, Silvia Armuzzi, Claudio Agostinelli, Alice Morigi, Beatrice Casadei, Cinzia Pellegrini, Vittorio Stefoni, Elena Sabattini, Lisa Argnani, Pier Luigi Luigi Zinzani
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia. Hematological oncology (2021)
Umberto Ricardi, Mario Levis, Andrea Evangelista, Daniela Maria Gioia, Gian Mauro Sacchetti, Manuel Gotti, Alessandro Re, Michela Buglione, Vincenzo Pavone, Antonio Nardella, Luca Nassi, Manuela Zanni, Paola Franzone, Giovanni Piero Frezza, Alessandro Pulsoni, Lavinia Grapulin, Armando Santoro, Luigi Rigacci, Gabriele Simontacchi, Monica Tani, Francesco Zaja, Elisabetta Abruzzese, Barbara Botto, Vittorio Ruggero Zilioli, Delia Rota-Scalabrini, Roberto Freilone, Giovannino Ciccone, Andrea Riccardo Filippi, Pier Luigi Luigi Zinzani
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. Blood advances 5 (21) (2021)
Paolo Elia Coppola, Alessandro Broccoli, Lisa Argnani, Beatrice Casadei, Vittorio Stefoni, Clara Bertuzzi, Elena Sabattini, Pier Luigi Luigi Zinzani
Rapid but reversible progression and transformation of chronic lymphocytic leukemia after temporary ibrutinib discontinuation due to off-target toxicity: two interesting cases. Leukemia & lymphoma (2021)
Nicolas Leupin, Pier Luigi Luigi Zinzani, Franck Morschhauser, Stéphane Dalle, Marie Maerevoet, Jean Marie Michot, Vincent Ribrag, Fritz Offner, Marie Beylot-Barry, Hélène Moins-Teisserenc, Karen Zwaenepoel, Koen de Winne, Maxime Battistella, Anna Hultberg, Domenica Gandini, Mahan Moshir, Julie Jacobs, Tim Delahaye, Aitzaz Khan, Piotr Zabrocki, Karen Silence, Luc van Rompaey, Christophe Borg, Giovanna Motta, Federica Melle, Angelica Calleri, Patrick Pauwels, Hans de Haard, Stefano Pileri, Martine Bagot
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma. Cancer (2021)
Michael Grever, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema Bhat, James S Blachly, Timothy Call, Matthew Cross, Claire Dearden, Judit Demeter, Sascha Dietrich, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Gunnar Juliusson, Eric Kraut, Robert J Kreitman, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Farhad Ravandi, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Enrico Tiacci, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines. Leukemia 35 (7) (2021)
Pier Luigi Luigi Zinzani, Thomas Rodgers, Dario Marino, Maurizio Frezzato, Anna Maria Barbui, Claudia Castellino, Erika Meli, Nathan H Fowler, Gilles Andre Salles, Bruce A Feinberg, Nuwan C Kurukulasuriya, Sascha Tillmanns, Stephan Parche, Debarshi Dey, Günter Fingerle-Rowson, Sumeet Ambarkhane, Mark Winderlich, Grzegorz S Nowakowski
RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Alessandra Rossi, Stefania Orecchioni, Paolo Falvo, Valentina Tabanelli, Elena Baiardi, Claudio Agostinelli, Federica Melle, Giovanna Motta, Angelica Calleri, Stefano Fiori, Chiara Corsini, Beatrice Casadei, Saveria Mazzara, Umberto Vitolo, Francesco Bertolini, Pier Luigi Luigi Zinzani, Myriam Alcalay, Pier Giuseppe Pelicci, Stefano Pileri, Corrado Tarella, Enrico Derenzini
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma. Leukemia (2021)
Maarten H Vermeer, J P Nicolay, Julia J Scarisbrick, Pier Luigi Luigi Zinzani
The importance of assessing blood tumour burden in cutaneous T-cell lymphoma. The British journal of dermatology 185 (1) (2021)
Francesca Romana Mauro, Francesca Paoloni, Stefano Molica, Gianluigi Reda, Livio Trentin, Paolo Sportoletti, Monia Marchetti, Daniela Pietrasanta, Roberto Marasca, Gianluca Gaidano, Marta Coscia, Caterina Stelitano, Donato Mannina, Nicola Di Renzo, Fiorella Ilariucci, Anna Marina Liberati, Lorella Orsucci, Francesca Re, Monica Tani, Gerardo Musuraca, Daniela Gottardi, Pier Luigi Luigi Zinzani, Alessandro Gozzetti, Annalia Molinari, Massimo Gentile, Annalisa Chiarenza, Luca Laurenti, Marzia Varettoni, Adalberto Ibatici, Roberta Murru, Valeria Ruocco, Ilaria Del Giudice, Maria Stefania De Propris, Irene Della Starza, Sara Raponi, Mauro Nanni, Paola Fazi, Antonino Neri, Anna Guarini, Gian Matteo Rigolin, Alfonso Piciocchi, Antonio Cuneo, Robin Foà
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. Cancers 14 (1) (2021)
Marco Pizzi, Claudio Agostinelli, Luisa Santoro, Marta Sbaraglia, Clara Bertuzzi, Luca Dal Santo, Alberto Friziero, Francesco Piazza, Pier Luigi Luigi Zinzani, Angelo Paolo Dei Tos, Elena Sabattini
Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: A word of caution. European journal of haematology 106 (5) (2021)
Ginevra Lolli, Beatrice Casadei, Cinzia Pellegrini, Lisa Argnani, Federica Cocito, Pier Luigi Luigi Zinzani
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report. Tumori 107 (6) (2021)
Stephen Samuel Opat, Alessandra Tedeschi, Kim Linton, Pamela McKay, Bei Hu, Henry Chan, Jie Jin, Magdalena Sobieraj-Teague, Pier Luigi Luigi Zinzani, Morton Coleman, Catherine Thieblemont, Peter Browett, Xiaoyan Ke, Mingyuan Sun, Robert Marcus, Craig A Portell, Kirit M Ardeshna, Fontanet Bijou, Patricia Walker, Eliza A Hawkes, Sally Mapp, Shir-Jing Ho, Dipti Talaulikar, Ke-Shu Zhou, Melannie Co, Xiaotong Li, Wenxiao Zhou, Massimo Cappellini, Chris Tankersley, Jane Huang, Judith Trotman
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Alessandro Broccoli, Lisa Argnani, Alice Morigi, Laura Nanni, Beatrice Casadei, Cinzia Pellegrini, Vittorio Stefoni, Pier Luigi Luigi Zinzani
Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience. Journal of clinical medicine 10 (24) (2021)
Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, Lodovico Terzi di Bergamo, Martin Richard Faderl, Valeria Spina, Adalgisa Condoluci, Luisella Bonomini, Gabriela Forestieri, Ricardo Koch, Deborah Piffaretti, Katia Pini, Maria C Pirosa, Micol Giulia Cittone, Alberto J Arribas, Marco Lucioni, Guido Ghilardi, Wei Wu, Luca Arcaini, Maria Joao Baptista, Gabriela Bastidas, Sílvia Beà, Renzo Boldorini, Alessandro Broccoli, Marco Matteo Bühler, Vincenzo Canzonieri, Luciano Cascione, Luca Ceriani, Sergio B Cogliatti, Paolo Corradini, Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaidano, Juan Fernando García, Bernhard Gerber, Paolo Ghia, Maria Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Ga Inghirami, Marco Ladetto, Armando López-Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Véronique Meignin, Michele Merli, Alden A Moccia, Manuela Mollejo, Carlos Montalban, Urban Novak, David Graham Oscier, Francesco Passamonti, Francesco A Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Andre Salles, Elisa Santambrogio, Lydia Scarfo, Anastasios Stathis, Georg Stussi, Julia Turbiner Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thieblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elias Campo, Laurence de Leval, Stefan Dirnhofer, Stefano A Pileri, Miguel A Piris, Alexandra Traverse-Glehen, Alexandar Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood (2021)
Martin Dreyling, Armando Santoro, Luigina Mollica, Sirpa Leppä, George Follows, Georg Lenz, Won Seog Kim, Arnon Nagler, Maria Dimou, Judit Demeter, Muhit Özcan, Marina Kosinova, Krimo Bouabdallah, Franck Morschhauser, Don A Stevens, David Trevarthen, Javier Munoz, Liana Rodrigues, Florian Hiemeyer, Ashok Miriyala, Jose Garcia-Vargas, Barrett H Childs, Pier Luigi Luigi Zinzani
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study. American journal of hematology 95 (4) (2020)
Marc P E André, Patrice Carde, Simonetta Viviani, Monica Bellei, Catherine Fortpied, Martin Hutchings, Alessandro M Gianni, Pauline Brice, Olivier Casasnovas, Paolo G Gobbi, Pier Luigi Luigi Zinzani, Jehan Dupuis, Emilio Iannitto, Alessandro Rambaldi, Josette Brière, Laurianne Clément-Filliatre, Marian Heczko, Pinuccia Valagussa, Jonathan Douxfils, Julien Depaus, Massimo Federico, Nicolas Mounier
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials. Cancer medicine 9 (18) (2020)
Ginevra Lolli, Alessandro Broccoli, Vittorio Stefoni, Lisa Argnani, Ornella Leone, Michele Cavo, Pier Luigi Luigi Zinzani
Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding. Tumori 106 (6) (2020)
Alice Morigi, Lisa Argnani, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Vittorio Stefoni, Paolo Elia Coppola, Matteo Carella, Beatrice Casadei, Elena Sabattini, Michele Cavo, Pier Luigi Luigi Zinzani
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients. Hematological oncology 38 (4) (2020)
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Vittorio Stefoni, Paolo E Coppola, Matteo Carella, Michele Cavo, Pier Luigi Luigi Zinzani
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma. Cancer medicine 9 (21) (2020)
Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, Elisabetta Bonifacio, Francesca Pregnolato, Francesco Angrilli, Umberto Vitolo, Samantha Pozzi, Serena Broggi, Stefano Luminari, Francesco Merli, Michele Spina, Silvia Bolis, Gloria Margiotta-Casaluci, Rosario Scalzulli, Christina Cox, Angela Maria Mamusa, Armando Santoro, Pier Luigi Luigi Zinzani, Samantha Ferrari, Guido Gini, Maria Luigia Vigliotti, Antonino Mulè, Leonardo Flenghi, null null
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity. Hematological oncology 38 (4) (2020)
Alice Morigi, Beatrice Casadei, Lisa Argnani, Vittorio Stefoni, Emanuela Sergio, Michele Cavo, Pier Luigi Luigi Zinzani
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma. Leukemia & lymphoma 62 (4) (2020)
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Vittorio Stefoni, Paolo Elia Coppola, Matteo Carella, Michele Cavo, Pier Luigi Luigi Zinzani
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients. Annals of hematology 100 (9) (2020)
Monia Marchetti, Elda Feyles, Pier Luigi Luigi Zinzani
Frontline Siltuximab and Rituximab in TAFRO syndrome: A case report. European journal of haematology 105 (4) (2020)
Matteo Carella, Vittorio Stefoni, Cinzia Pellegrini, Lisa Argnani, Michele Cavo, Pier Luigi Luigi Zinzani
Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma. Tumori 106 (6) (2020)
Danilo Fiore, Luca Vincenzo Cappelli, Alessandro Broccoli, Pier Luigi Luigi Zinzani, Wing C John Chan, Giorgio Ga Inghirami
Peripheral T cell lymphomas: from the bench to the clinic. Nature reviews. Cancer 20 (6) (2020)
Ginevra Lolli, Lisa Argnani, Alessandro Broccoli, Miriam Marangon, Cinzia Pellegrini, Alice Morigi, Beatrice Casadei, Laura Nanni, Vittorio Stefoni, Matteo Carella, Michele Cavo, Pier Luigi Luigi Zinzani
90 Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study. British journal of haematology 189 (1) (2020)
Miriam Marangon, Beatrice Casadei, Alessandro Broccoli, Lisa Argnani, Michele Cavo, Pier Luigi Luigi Zinzani
Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report. Clinical case reports 8 (6) (2020)
David C Fajgenbaum, David Wu, Aaron Goodman, Raymond Siu Ming Wong, Amy Chadburn, Sunita Nasta, Gordan Srkalovic, Sudipto Mukherjee, Heather Leitch, Raj Jayanthan, Simone Ferrero, Yasuharu Sato, Steve Schey, Angela Dispenzieri, Eric Oksenhendler, Pier Luigi Luigi Zinzani, Mary Jo Lechowicz, Christian Hoffmann, Naveen Pemmaraju, Adam Bagg, Alexander Fossa, Megan S Lim, Frits van Rhee, null null
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. American journal of hematology 95 (12) (2020)
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini, Laura Nanni, Vittorio Stefoni, Paolo Elia Coppola, Matteo Carella, Michele Cavo, Pier Luigi Luigi Zinzani
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience. Hematological oncology 38 (5) (2020)
Alessandro Broccoli, Cristina Nanni, Alberta Cappelli, Francesco Bacci, Alessandro Gasbarrini, Elena Tabacchi, Carlo Piovani, Lisa Argnani, Riccardo Ghermandi, Elena Sabattini, Rita Golfieri, Stefano Fanti, Pier Luigi Luigi Zinzani
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma. European journal of nuclear medicine and molecular imaging 47 (13) (2020)
Alessandro Pileri, M Starace, Aurora Maria Alessandrini, B Casadei, Pier Luigi Luigi Zinzani, B M Piraccini
New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia. The British journal of dermatology 180 (6) (2019)
Alessandro Broccoli, Clara Bertuzzi, Michelangelo Fiorentino, Alice Morigi, Vittorio Stefoni, Claudio Agostinelli, Lisa Argnani, Michele Cavo, Pier Luigi Luigi Zinzani
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia. OncoTargets and therapy 12 (2019)
Alice Morigi, Beatrice Casadei, Lisa Argnani, Michele Cavo, Pier Luigi Luigi Zinzani
Spontaneous remission of follicular lymphoma. Hematological oncology 37 (5) (2019)

Pier Luigi Luigi Zinzani.css-eqlu8i{font-size:small;padding-left:4px;} (Pierluigi Luigi Zinzani, P L Zinzani, PierLuigi Zinzani, Pier L Zinzani, Pierluigi Zinzani, Pier Luigi Zinzani, Pier-Luigi Zinzani)

Publication Activity (10 Years)

Top Topics

Top Venues

Pier Luigi Luigi Zinzani (Pierluigi Luigi Zinzani, P L Zinzani, PierLuigi Zinzani, Pier L Zinzani, Pierluigi Zinzani, Pier Luigi Zinzani, Pier-Luigi Zinzani)